{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:56:26Z","timestamp":1790664986470,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"21","license":[{"start":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T00:00:00Z","timestamp":1540425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red"},{"DOI":"10.13039\/501100012513","name":"CIBERCV","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00425"],"award-info":[{"award-number":["CB16\/11\/00425"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Diabetes mellitus (DM) aggravates the clinical features of ischaemic and hypertensive heart diseases and worsens the prognosis of heart failure patients. Hypertrophic cardiomyopathy (HCM) and diabetes coexist fairly frequently in elderly patients but the impact of DM on the clinical phenotype of HCM is yet unknown. We sought to describe if predominant features of heart failure in DM patients exist independently in HCM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We reviewed clinical characteristics of 937 patients, age \u226540, diagnosed with HCM, from two tertiary medical centres in Spain and Israel. A propensity score matched cohort of 294 patients was also analysed. Our cohort comprised 102 HCM patients with diabetes (8.7%). Patients with DM were older at diagnosis {median 56 [interquartile range (IQR) 47\u201367] vs. 53 (IQR 43\u201363), P\u2009=\u20090.02} and had a higher prevalence of comorbidities. Hypertrophic cardiomyopathy patients with DM had a higher prevalence of diastolic dysfunction, pulmonary hypertension, significant mitral regurgitation, and pacemaker implantation. Hypertrophic cardiomyopathy patients with DM had a higher New York Heart Association (NYHA) class (P\u2009&amp;lt;\u20090.001) and lower exercise capacity [7.0 METS (IQR 5.0\u201310.0) vs. 9.0 METS (IQR 6.6\u201311.0), P\u2009=\u20090.002]. These findings were independent of age, gender, country of origin, hypertension, and coronary artery disease. Patients with diabetes had a significantly higher 15-year mortality (22% vs. 15%, P\u2009=\u20090.03), with no differences in sudden cardiac death, appropriate implanted cardioverter-defibrillator therapy, or heart transplantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Hypertrophic cardiomyopathy patients with diabetes are older and have a higher cardiovascular risk profile. They have a lower functional capacity and more heart failure symptoms due to diastolic dysfunction.<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehy625","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T20:26:41Z","timestamp":1537388801000},"page":"1671-1677","source":"Crossref","is-referenced-by-count":69,"title":["The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathy"],"prefix":"10.1093","volume":"40","author":[{"given":"Yishay","family":"Wasserstrum","sequence":"first","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Barriales-Villa","sequence":"additional","affiliation":[{"name":"Inherited Cardiovascular Diseases Unit, Cardiology Service, Complexo Hospitalario Universitario A Coru\u00f1a, Servizo Galego de Sa\u00fade (SERGAS), Universidade da Coru\u00f1a, A Coru\u00f1a, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusto","family":"Fern\u00e1ndez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), A Coru\u00f1a, Spain"},{"name":"Health in Code S.L., Cardiology Department, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Adler","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dor","family":"Lotan","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Peled","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klempfner","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Kuperstein","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Shlomo","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Sabbag","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Freimark","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monserrat","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a (INIBIC), A Coru\u00f1a, Spain"},{"name":"Health in Code S.L., Cardiology Department, A Coru\u00f1a, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Arad","sequence":"additional","affiliation":[{"name":"Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,25]]},"reference":[{"key":"2022102609510530300_ehy625-B1","first-page":"2733","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2015","journal-title":"Eur Heart J"},{"key":"2022102609510530300_ehy625-B2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.83.6.580","article-title":"Familial hypertrophic cardiomyopathy: from mutations to functional defects","volume":"83","author":"Bonne","year":"1998","journal-title":"Circ Res"},{"key":"2022102609510530300_ehy625-B3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11886-000-0010-9","article-title":"Molecular genetics of hypertrophic cardiomyopathy","volume":"2","author":"Towbin","year":"2000","journal-title":"Curr Cardiol Rep"},{"key":"2022102609510530300_ehy625-B4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ahj.2016.07.025","article-title":"Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get With The Guidelines\u2013Heart Failure registry","volume":"182","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Am Heart J"},{"key":"2022102609510530300_ehy625-B6","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2337\/diacare.26.5.1421","article-title":"Multiple hospitalizations for patients with diabetes","volume":"26","author":"Jiang","year":"2003","journal-title":"Diabetes Care"},{"key":"2022102609510530300_ehy625-B7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"Am J Cardiol"},{"key":"2022102609510530300_ehy625-B8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.0000045671.62860.98","article-title":"Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study","volume":"107","author":"Rutter","year":"2003","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022102609510530300_ehy625-B11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jcp.46.1.32","article-title":"Collagen remodelling in myocardia of patients with diabetes","volume":"46","author":"Shimizu","year":"1993","journal-title":"J Clin Pathol"},{"key":"2022102609510530300_ehy625-B12","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/eci.12673","article-title":"Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?","volume":"46","author":"Mizamtsidi","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"2022102609510530300_ehy625-B13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"2022102609510530300_ehy625-B14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cardfail.2010.07.249","article-title":"Diabetic cardiomyopathy","volume":"16","author":"Murarka","year":"2010","journal-title":"J Card Fail"},{"key":"2022102609510530300_ehy625-B15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000064682","article-title":"Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy","volume":"98","author":"Schannwell","year":"2002","journal-title":"Cardiology"},{"key":"2022102609510530300_ehy625-B16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/hc1002.105185","article-title":"Progression of systolic abnormalities in patients with \u201cisolated\u201d diastolic heart failure and diastolic dysfunction","volume":"105","author":"Yu","year":"2002","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B17","first-page":"186","article-title":"The nature of cardiac hypertrophy in acromegaly: an echocardiographic study","volume":"30","author":"Hradec","year":"1988","journal-title":"Cor Vasa"},{"key":"2022102609510530300_ehy625-B18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1378\/chest.109.5.1394","article-title":"Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy","volume":"109","author":"Huddle","year":"1996","journal-title":"Chest"},{"key":"2022102609510530300_ehy625-B19","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.2337\/diacare.26.10.2764","article-title":". Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study","volume":"26","author":"Palmieri","year":"2003","journal-title":"Diabetes Care"},{"key":"2022102609510530300_ehy625-B20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.diabet.2008.12.004","article-title":"Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function","volume":"35","author":"Blanchet Deverly","year":"2009","journal-title":"Diabetes Metab"},{"key":"2022102609510530300_ehy625-B21","doi-asserted-by":"crossref","first-page":"757.","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"2022102609510530300_ehy625-B22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCULATIONAHA.105.576652","article-title":"Gender differences in outcomes after hospital discharge from coronary artery bypass grafting","volume":"113","author":"Guru","year":"2006","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102609510530300_ehy625-B24","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCULATIONAHA.107.728550","article-title":"Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension","volume":"117","author":"van Heerebeek","year":"2008","journal-title":"Circulation"},{"key":"2022102609510530300_ehy625-B26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.yjmcc.2010.02.012","article-title":"Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy","volume":"48","author":"Kr\u00fcger","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2022102609510530300_ehy625-B27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","article-title":"Diabetic cardiomyopathy: bench to bedside","volume":"8","author":"Schilling","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2022102609510530300_ehy625-B28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellsig.2011.09.007","article-title":"Healing the diabetic heart: does myocardial preconditioning work?","volume":"24","author":"Balakumar","year":"2012","journal-title":"Cell Signal"},{"key":"2022102609510530300_ehy625-B29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yexcr.2016.11.016","article-title":"Caloric restriction ameliorates cardiomyopathy in animal model of diabetes","volume":"350","author":"Cohen","year":"2017","journal-title":"Exp Cell Res"},{"key":"2022102609510530300_ehy625-B30","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/hrt.2003.020842","article-title":"Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes","volume":"90","author":"von Bibra","year":"2004","journal-title":"Heart"},{"key":"2022102609510530300_ehy625-B31","first-page":"S48","article-title":"Standards of Medical Care in Diabetes: 6. Glycemic Targets","volume":"40(Suppl. 1)","year":"2017","journal-title":"Diabetes Care"},{"key":"2022102609510530300_ehy625-B32","doi-asserted-by":"crossref","first-page":"1349.","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"2022102609510530300_ehy625-B33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2022102609510530300_ehy625-B34","first-page":"103","article-title":"Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients","volume":"59","author":"Orea-Tejeda","year":"2007","journal-title":"Rev Invest Clin"},{"key":"2022102609510530300_ehy625-B35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","article-title":"Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials","volume":"146","author":"Haas","year":"2003","journal-title":"Am Heart J"},{"key":"2022102609510530300_ehy625-B36","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1378\/chest.128.4.2611","article-title":"Increased prevalence of third-degree atrioventricular block in patients with type II diabetes mellitus","volume":"128","author":"Movahed","year":"2005","journal-title":"Chest"},{"key":"2022102609510530300_ehy625-B37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1463-1326.2006.00609.x","article-title":"Diabetes as a risk factor for cardiac conduction defects: a review","volume":"9","author":"Movahed","year":"2007","journal-title":"Diabetes Obes Metab"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/21\/1671\/46639458\/eurheartj_40_21_1671.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/21\/1671\/46639458\/eurheartj_40_21_1671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T09:53:29Z","timestamp":1666778009000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/21\/1671\/5144691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,25]]},"references-count":37,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2018,10,25]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy625","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2018,10,25]]}}}